RCT
A Study Utilising Tissue From Deceased Organ Donors to Investigate Regenerative Cellular Therapies and Related Physiological and Developmental Processes
Sponsor study identifier
Secondary identifiers
OTHER · Research Ethics Committee
observational
50
1 country
1
Study Start
January 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study aims to use tissue from deceased organ donors to investigate organ physiology, developmental biology, as well as the development of future regenerative cellular therapies. It will investigate function and immune response to stem cells as well as their generation from adult cells and generation of induced pluripotent stem cells (iPSCs).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 9, 2015
Actual (reported)June 11, 2015
Actual (reported)January 2016
Date type not reportedThis date has not been verified as actual or estimated.
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Number of donors from which induced Pluripotent Stem Cells were generated
5 years
Number of stem cell lines for which the immune response was characterised
5 years
Number of immunomodulatory therapies characterised
5 years
Levels of baseline and stimulated gut hormones detected
Patients with consent for organ donation towards transplantation and research. Organs not used for transplantation will be used for this study if determined appropriate and necessary.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All deceased organ donors for whom informed consent is available from the donor family
Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
DNA data from tissue samples from donated organs may be retained anonymously for a period up to 10 years
Kourosh Saeb-Parsy, PhD, FRCS
Cambridge Univeristy Hospitals
First Submitted
June 9, 2015
First Posted
June 11, 2015
Study Start
January 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2020
StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With Diabetes
5 years
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 14, 2016
Record last verified: 2016-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: